two new cholesterol-lowering drugs, Kynamro (kye-NAM-roe, mipomersen) and Juxtapid (JUKS-tuh-pid, lomitapide)

You'll hear about two new cholesterol-lowering drugs, Kynamro (kye-NAM-roe, mipomersen) and Juxtapid (JUKS-tuh-pid, lomitapide).

But they're NOT for the vast majority of lipid patients.

They're for patients with homozygous familial hypercholesterolemia...which occurs in about one in 1,000,000 people.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote